ImageneBio (IMA) Enterprise Value (2021 - 2025)

ImageneBio has disclosed Enterprise Value across 5 years of filings, most recently posting -$76.5 million for Q4 2025.

• In Q4 2025, Enterprise Value fell 154.24% year-over-year to -$76.5 million; the TTM figure through Dec 2025 stood at -$76.5 million (down 154.24% YoY), while the FY2025 annual figure was -$107.6 million, down 176.28% from the prior year.
• Enterprise Value came in at -$76.5 million for Q4 2025 at ImageneBio, down from -$73.1 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of $239.4 million in Q2 2021 to a low of -$172.2 million in Q1 2021.
• Average Enterprise Value over 5 years is -$883226.3, with a median of -$38.9 million recorded in 2022.
• Year-over-year, Enterprise Value surged 472.94% in 2023 and plunged 814.13% in 2024.
• Over 5 years, Enterprise Value stood at $118.7 million in 2021, then tumbled by 150.98% to -$60.5 million in 2022, then plunged by 32.88% to -$80.4 million in 2023, then surged by 275.46% to $141.1 million in 2024, then slumped by 154.24% to -$76.5 million in 2025.
• Per Business Quant data, the three most recent Enterprise Value figures were -$76.5 million in Q4 2025, -$73.1 million in Q3 2025, and -$31.0 million in Q2 2025.